We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Arena Pharmaceuticals

News List

Arena Pharmaceuticals Reports Topline Results from Atopic Dermatitis Trial americanpharmaceuticalreview
November 20, 2020
Arena Pharmaceuticals announced topline results from the Phase 2b ADVISE clinical trial evaluating etrasimod, a highly selective, once-daily, oral sphingosine 1-phosphate (S1P) receptor modulator, for the treatment of moderate-to-severe atopic dermatitis.
Arena Pharmaceuticals Shares Explode on Positive Ulcerative Colitis Trial Data biospace
March 21, 2018
Arena Pharmaceuticals, Inc. shares rose 34 percent in premarket trading today after the company released positive top-line results from its Phase II trial of etrasimod in ulcerative colitis.
Arena Pharmaceuticals Appoints Executive Vice President, Research and Development and Chief Medical americanpharmaceuticalreview
March 21, 2017
Arena Pharmaceuticals, Inc. has announced the appointment of Dr. Preston Klassen, M.D., M.H.S. as Executive Vice President, Research and Development and Chief Medical Officer. Dr. Klassen will report to Amit Munshi, Arena's President and Chief Executive O